Akciğer Kanserlerine Eşlik Eden Plevra Sıvısı
PDF
Cite
Share
Request
P: 109-113
2009

Akciğer Kanserlerine Eşlik Eden Plevra Sıvısı

Acta Haematol Oncol Turc 2009;42(3):109-113
1. Düzce Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, DÜZCE
2.
No information available.
No information available
Received Date: 2014-08-28T17:06:35
PDF
Cite
Share
Request

Abstract

İt has been known that prognosis is poor in lung cancer vvith pleural effusion. The records of 44 lung cancer patients vvith pleural effusion admitted to our clinic betvveen 2003-2009 were evaluated. Thirty nine patients (88.6%) were male and five of them were (11.4%) femaie. Mean age of patients was 62.8 ± 11.7 (minimum 36-maximum 93) years. Thirty three patients (75.0%) were diagnosed as non small celi lung cancer (NSCLC) whereas remaining (25.0%) were presented as small celi lung cancer. Most of the cases (16/33) were diagnosed as sçuamous celi cancer in patients vvith NSCLC vvhereas the remaining were ade-nocarcinoma (seven cases), large celi cancer (two cases) and non-classified NSCLC (eight cases). The stages in most of the cases were presented as T4 (43.2%), N1 (27.3%), MO (43.2%) and stage (36.4%). Pleural effusion was in right side (43.2%) and minimal (45.5%) in size in the majority of cases. Most of the pleural effusions were in the same side vvith tumor (88.6%>), were exudative (61.4%>) and were not evaluated microscopically (61.4%). The ratio of the patients undement chemotherapy and presented vvith regression in pleural effusion was high after the first course then it decreased in the later courses (39.1 %> -»9.1 %>). The ratio of patients vvhose effusions remained stable after the first course increased in the later courses and remained above 50% (56.6%> -»63.6%>). The ratio of patients vvith Progressive pleural effusions increased in the later courses (4.3%> ->27.3%o). İn conclusion; pleural effusion might be mostly seen in the later stages of lung cancer. Most of the pleural effusions were minimal and located at the same side vvith tumor. The regression response that was achieved in the first course of chemotherapy decreased in the later courses. Progression in pleural effusions increased in the later courses.